UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
(Exact name of registrant as specified in its charter)
|
| |||
(State or other jurisdiction of | (Commission | (I.R.S. Employer | ||
incorporation or organization) | File Number) | Identification No.) |
| ||
(Address of principal executive offices) | (Zip Code) |
(
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Operating Officer Retirement
On April 21, 2022, Merit Medical Systems, Inc. (the “Company”) announced that Ron Frost has retired from his position as the Company’s Chief Operating Officer, effective April 19, 2022.
Appointment of Executive Officer
On April 21, 2022, the Company announced that, effective April 19, 2022, Neil Peterson, age 56, was appointed as the Company’s Chief Operating Officer. Prior to this appointment, Mr. Peterson served as the Company’s Vice President, Operations for the past five years, and he has been with the Company in various positions for the past 27 years.
Mr. Peterson is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K, and does not have any family relationship with any other executive officer or board member required to be disclosed pursuant to Item 404(d) of Regulation S-K.
Item 8.01. Other Events.
On April 21, 2022, the Company issued a press release announcing the retirement of Ron Frost as the Company’s Chief Operating Officer and the appointment of Neil Peterson as the Company’s Chief Operating Officer.
The Company’s press release announcing the retirement and appointment is included as Exhibit 99.1 of this report.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Exhibit No. |
| Exhibit |
99.1 | ||
104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MERIT MEDICAL SYSTEMS, INC. | ||
Date: April 22, 2022 | By: | /s/ Brian G. Lloyd |
Brian G. Lloyd | ||
Chief Legal Officer and Corporate Secretary |
3